SPAGN Conference 2024: TGCT - Diagnosis Disclosure

[@luvleeleeanne]

Thank you so much for this information. I just wish that we have access to different treatment options here in Australia.

[@tgctsupport3596]

We hear you! This is one of our major advocacy efforts this year, to try to make Australian providers aware of new options likely coming to them very soon (hopefully starting with vimseltinib). We have an Australian oncologist on our advisory board, Dr Bhadri, and he has been helpful to develop strategies. We won’t stop until you have more options!